Evidence map›Paper›PMID 39488692›Full record

ArticleRadiation oncology (London, England)2024

3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes.

Zenghong Lu, Gangfeng Zhu, Zhengang Qiu, Hailiang Guo, Junyan Li, Liangjian Zheng, Cixiang Chen, Jie Che, Yi Xiang, Yili Wang

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zenghong Lu *Department of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Gangfeng Zhu *First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Zhengang QiuDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Hailiang GuoDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Junyan LiFirst Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Liangjian ZhengFirst Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Cixiang ChenFirst Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China.
Jie CheFirst Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China. 609687943@qq.com.
Yi XiangDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China. xiangyi_xiangyi@126.com.
Yili WangDepartment of Oncology, The First Affiliated Hospital, Gannan Medical University, Ganzhou, 341000, Jiangxi Province, China. wyllzt@aliyun.com.

Funding

The Basic Research Fund, First Affiliated Hospital of Gannan Medical University QD095
6 · The paper itself

Abstract

objectiveThis study aims to evaluate the efficacy and safety of 3D printing technology in brachytherapy for cervical cancer, comparing its outcomes with conventional free hand implantation brachytherapy.

methodsA total of 50 cervical cancer patients treated at the First Affiliated Hospital of Gannan Medical College from January 2019 to July 2023 were included in this study. Patients were divided into two groups: 25 patients received intensity-modulated radiotherapy (IMRT) combined with 3D-printed brachytherapy, and 25 patients underwent IMRT combined with free hand brachytherapy implantation. Key indicators analyzed included short-term therapeutic effects, survival outcomes, operation times, the number of CT scans, the number of needles inserted, dosimetric parameters, and complications.

resultsThe use of 3D-printed brachytherapy significantly improved the safety of radiation therapy operations, especially for large tumors (≥ 30 mm), by providing more precise dose distribution and reducing the radiation doses received by critical organs such as the bladder and rectum. Compared to the artificial implant group (88% prevalence), the 3D-printed brachytherapy group showed a significantly lower incidence of radiation enteritis (29.2% prevalence, p < 0.001). There were no significant differences in other complications between the two groups. For instance, the incidence of radiation cystitis was relatively high in the 3D-printed brachytherapy group (79.2% prevalence) compared to the artificial implant group (64% prevalence, p = 0.240). The median follow-up period in this study was 22.5 months [IQR 18-29]. Among the 49 patients included, 43 had cervical squamous carcinoma and 6 had cervical adenocarcinoma. Short-term therapeutic response rates were comparable, with no significant difference in overall survival observed between the two groups.

conclusion3D-printed brachytherapy offers a more effective and safer therapeutic option for patients with cervical cancer, particularly for those with large tumors or complex anatomical structures.

Indexed as

BrachytherapyPrinting, Three-DimensionalRadiotherapy DosageUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedTreatment Outcome3D printing technologyBrachytherapyCervical cancerSafetyTreatment efficacy

Identifiers

PMID39488692
PMCPMC11531177

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.